[ad_1] Granules India Ltd shares gained 2.12% to hit an all-time high of ₹666.3 apiece on BSE on Friday, August 9, after the US Food and Drug Administration (USFDA) approved its Abbreviated New Drug Application (ANDA) for Trazodone Hydrochloride Tablets USP. Trazodone tablets are indicated for the treatment of major depressive disorder in adults. In […]
Headline
Tag: Granules USFDA approval for antidepressant drug
Back To Top